11 March 2016 – Tate & Lyle PLC
Tate & Lyle PLC (the "Company") announces that Lars Frederiksen and Sybella Stanley have been appointed as Non-Executive Directors with effect from 1 April 2016. Details of the new appointees are set out below.
Sir Peter Gershon, Chairman of Tate & Lyle, said “We are delighted that Lars and Sybella have agreed to join us. Lars's considerable understanding of the global food ingredients industry and Sybella's extensive commercial and financial experience will be of great benefit to the Board as we progress the delivery of the Group's strategy.”
Lars was CEO of Chr. Hansen Holding A/S from 2005 until his retirement in March 2013, leading a transformation of the business and a successful listing on the Copenhagen stock exchange during that period. Prior to his appointment as CEO, Lars held various management positions at Chr. Hansen, including Executive Vice President, International Operations, Executive Vice President, Bio Ingredients Division and Executive Vice President, Dairy Ingredients Division. He is based in Denmark and has a portfolio of directorships, including serving as Chairman of the Board and of the Compensation and Nomination Committees of Matas A/S, non-executive director of Falck A/S and Rockwool A/S and Chairman of the Danish Committee for Good Corporate Governance. Lars will join the Remuneration, Corporate Responsibility and Nominations Committees on his appointment.
Sybella is Director of Corporate Finance at RELX Group plc (formerly Reed Elsevier Group plc), where she is responsible for global mergers and acquisitions. Sybella originally qualified as a barrister and before joining RELX Group in 1997, she was a member of the M&A advisory teams at Citigroup and later Barings. Based in the UK, Sybella is a non-executive director of The Merchants Trust PLC, a member of the Department of Business, Innovation and Skills’ Industrial Development Advisory Board, a trustee of the Britten-Pears Foundation and a member of the Somerville College Oxford Development Board. Sybella will join the Audit and Nominations Committees on her appointment.
There are no further disclosures to be made pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.
For more information contact Tate & Lyle PLC:
Christopher Marsh, VP, Investor and Media Relations
Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688
Andrew Lorenz (FTI Consulting), Media Relations
Tel: +44 (0) 203 727 1323 or Mobile: +44 (0) 7775 641 807
About Tate & Lyle:
Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.
Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.
Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.
Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2015, Tate & Lyle sales totalled £2.4 billion. For more information, please visit http://www.tateandlyle.com. SPLENDA® is a trademark of Heartland Consumer Products LLC.